Atrás
41
Rango del Día
$67.02
$68.55
Rango de 52 Semanas
$66.49
$107.27
Volumen
1,152,697
Promedio 50D / 200D
$78.50
/
$84.96
Cierre Anterior
$66.71
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 31.5 | 0.4 |
| P/B | 2.6 | 2.9 |
| ROE % | 8.7 | 3.8 |
| Net Margin % | 8.5 | 3.9 |
| Rev Growth 5Y % | 9.0 | 10.0 |
| D/E | 0.6 | 0.2 |
Precio Objetivo de Analistas
Hold
$100.67
+47.8%
Low: $78.00
High: $108.00
P/E Futuro
16.8
EPS Futuro
$4.06
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
1.6 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$5.23
$5.16 – $5.31
|
2.1 B | 1 |
| FY2029 |
$4.97
$4.90 – $5.05
|
1.9 B | 1 |
| FY2028 |
$4.65
$4.44 – $4.85
|
1.8 B | 2 |
Puntos Clave
Revenue grew 8.98% annually over 5 years — modest growth
Generating 215.65M in free cash flow
P/E of 31.51 — premium valuation
Cash machine — converts 167.84% of earnings into free cash flow
Capital efficient — spends only 5.39% of revenue on capex
Crecimiento
Revenue Growth (5Y)
8.98%
Revenue (1Y)11.75%
Earnings (1Y)6.76%
FCF Growth (3Y)41.01%
Calidad
Return on Equity
8.67%
ROIC5.58%
Net Margin8.48%
Op. Margin12.19%
Seguridad
Debt / Equity
0.57
Current Ratio4.34
Interest Coverage6.98
Valoración
P/E Ratio
31.51
P/B Ratio2.56
EV/EBITDA24.35
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.75% | Revenue Growth (3Y) | 9.80% |
| Earnings Growth (1Y) | 6.76% | Earnings Growth (3Y) | 16.66% |
| Revenue Growth (5Y) | 8.98% | Earnings Growth (5Y) | 27.61% |
| Profitability | |||
| Revenue (TTM) | 1.52B | Net Income (TTM) | 128.49M |
| ROE | 8.67% | ROA | 4.78% |
| Gross Margin | 48.70% | Operating Margin | 12.19% |
| Net Margin | 8.48% | Free Cash Flow (TTM) | 215.65M |
| ROIC | 5.58% | FCF Growth (3Y) | 41.01% |
| Safety | |||
| Debt / Equity | 0.57 | Current Ratio | 4.34 |
| Interest Coverage | 6.98 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 31.51 | P/B Ratio | 2.56 |
| P/S Ratio | 2.67 | PEG Ratio | 8.40 |
| EV/EBITDA | 24.35 | Dividend Yield | 0.00% |
| Market Cap | 4.05B | Enterprise Value | 4.50B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.52B | 1.36B | 1.26B | 1.15B | 1.07B |
| Net Income | 128.49M | 120.36M | 94.41M | 74.52M | 48.45M |
| EPS (Diluted) | 2.13 | 2.03 | 1.62 | 1.29 | 0.84 |
| Gross Profit | 738.27M | 643.33M | 583.87M | 519.10M | 485.33M |
| Operating Income | 184.72M | 155.69M | 123.94M | 87.56M | 60.92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.69B | 2.42B | 2.33B | 1.66B | 1.65B |
| Total Liabilities | 1.10B | 1.04B | 1.12B | 519.57M | 608.50M |
| Shareholders' Equity | 1.58B | 1.38B | 1.20B | 1.14B | 1.04B |
| Total Debt | 898.23M | 794.67M | 891.36M | 279.76M | 325.70M |
| Cash & Equivalents | 448.50M | 376.72M | 587.04M | 58.41M | 67.75M |
| Current Assets | 1.04B | 923.77M | 1.11B | 529.08M | 482.21M |
| Current Liabilities | 239.76M | 216.40M | 203.56M | 220.65M | 236.28M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#594 of 1024
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026